Wednesday, Jan 17, 2018
engineered enzymes for better healthcare

Homocystinuria (HCY) is caused by an enzyme deficiency that blocks the metabolism of homocysteine and occurs in approximately 1 in every 68,000 (Ireland). The major clinical features include optical dislocation (affecting 80% of HCY by age 15), mental retardation, osteoporosis and thromboembolism causing death in 50% of HCY by age 20 and 75% by age 30. With early detection, strict dietary management and vitamin supplements, growth and development should be normal.

Product Info

 

amino acid disorders productDisorders of Amino Acid Metabolism

PKU        Phenylketonuria

MSUD     Maple Syrup Urine Disease

HCY        Homocystinuria

TYR-I      Tyrosinaemia Type-I

 

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...